Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Biohaven Ltd. (BHVN) and Arrowhead Pharmaceuticals (ARWR)
Buy Rating Affirmed on Biohaven Ltd. Amidst Pipeline Potential and Upcoming Developments
RBC Capital Sticks to Their Buy Rating for Biohaven Ltd. (BHVN)
Analysts Are Bullish on Top Healthcare Stocks: Biohaven Ltd. (BHVN), Becton Dickinson (BDX)
Buy Rating Affirmed for Biohaven Ltd. Amid Positive Clinical Outlook and Pipeline Potential
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Zoetis (ZTS) and Ginkgo Bioworks Holdings (DNA)
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), AstraZeneca (AZN) and Biohaven Ltd. (BHVN)
Buy Rating Affirmed: Biohaven Ltd. Poised for Key Milestones With Diverse Portfolio and Promising Lead Molecule BHV-7000
Buy Rating Affirmed for Biohaven Ltd. on Strong Pipeline and Upcoming Drug Advancements
Piper Sandler Remains a Buy on Biohaven Ltd. (BHVN)
Analysts Offer Insights on Healthcare Companies: Seer (SEER) and Biohaven Ltd. (BHVN)
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Waters (WAT) and Biohaven Ltd. (BHVN)
Biohaven Ltd. Poised for Growth: A Buy Rating Justified by Clinical Advances and Pipeline Expansion
Buy Rating for Biohaven Ltd. on Strong Drug Pipeline and Market Expansion Potential
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Precision BioSciences (DTIL) and Healthequity (HQY)
Buy Rating for Biohaven Ltd. on Strong BHV-7000 Prospects in MDD and Epilepsy Markets
Buy Rating for Biohaven Ltd.: Promising Developments in BHV-1300 and BHV-7000 Programs and Potential Offset of Operating Expenses
Positive Prospects for Biohaven Ltd: A Comprehensive Financial & Clinical Update With Buy Rating
Biohaven Ltd. (BHVN) Gets a Buy From Piper Sandler
Promising Future for Biohaven Ltd.: A Comprehensive Analysis of Its Prospects and Buy Rating Justification
No Data